Securities code: 688607 securities abbreviation: Careray Digital Medical Technology Co.Ltd(688607) Announcement No.: 2022-009 Careray Digital Medical Technology Co.Ltd(688607)
Announcement of resolutions of the sixth (Interim) meeting of the second board of directors
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.
1、 Meetings of the board of directors
The sixth (Interim) meeting of the second board of directors of Careray Digital Medical Technology Co.Ltd(688607) (hereinafter referred to as “the company”) was held at 9:30 a.m. on February 15, 2022 in the conference room of the company by on-site combined with communication voting. The meeting notice was sent to all directors by e-mail and telephone on February 13, 2022. The meeting was presided over by the chairman, Mr. Jiang Liu (Liu Jianqiang). There were 9 directors who should attend the meeting and 9 actually attended the meeting. The convening and convening procedures of this meeting comply with the provisions of relevant laws, administrative regulations, departmental rules, normative documents and the articles of association.
2、 Deliberations of the board of directors
The directors attending the meeting carefully considered the following proposals and voted on the following matters:
1. The proposal on granting restricted shares to incentive objects for the first time was deliberated and adopted
In accordance with the relevant provisions of the measures for the administration of equity incentive of listed companies, the rules for the listing of shares on the science and Innovation Board of Shanghai Stock Exchange, the self regulatory guide for listed companies on the science and Innovation Board No. 4 – disclosure of equity incentive information and the company’s restricted stock incentive plan (Draft) in 2022, As well as the authorization of the company’s first extraordinary general meeting of shareholders in 2022 held on February 11, 2022, the board of directors considered that the granting conditions specified in the company’s restricted stock incentive plan in 2022 had been met, and agreed to determine February 15, 2022 as the first granting date of the incentive plan to grant a total of 3209000 restricted shares to 99 incentive objects who met the granting conditions, The grant price is 17.64 yuan / share.
All independent directors of the company have expressed their independent opinions with explicit consent.
Voting results: 5 in favor, 0 against, 0 abstention and 4 avoidance. Mr. Jiang Liu (Liu Jianqiang), Mr. Gao Peng, Ms. Zhang Ping and Mr. Liu Jianguo, as affiliated directors, avoided voting on this proposal.
For details, please refer to the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Announcement of Careray Digital Medical Technology Co.Ltd(688607) on granting restricted shares to incentive objects for the first time (Announcement No.: 2022-011) disclosed on.
2. Deliberated and passed the proposal on the proposed investment in the establishment of a wholly-owned subsidiary
Based on the company’s strategic planning and business development, the company plans to set up a wholly-owned subsidiary in Singapore with a total investment of no more than US $15 million.
According to the relevant provisions of the Listing Rules of Shanghai Stock Exchange on the science and innovation board and the articles of association, this foreign investment is still within the approval authority of the board of directors of the company and does not need to be deliberated by the general meeting of shareholders. The board of directors of the company authorizes the management of the company to handle specific matters related to the establishment of wholly-owned subsidiaries, including but not limited to handling approval and filing procedures with relevant Chinese departments, as well as the preparation of articles of association and registration of wholly-owned subsidiaries required for the establishment of wholly-owned subsidiaries.
Voting results: 9 in favor, 0 against, 0 abstention and 0 avoidance.
For details, please refer to the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Announcement of Careray Digital Medical Technology Co.Ltd(688607) on foreign investment and establishment of wholly-owned subsidiaries (Announcement No.: 2022-012) disclosed on the.
It is hereby announced.
Careray Digital Medical Technology Co.Ltd(688607) board of directors February 16, 2022
